163 related articles for article (PubMed ID: 7452464)
41. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides.
Saito M; Ugajin T; Nozawa Y; Sadzuka Y; Miyagishima A; Sonobe T
Int J Pharm; 2002 Dec; 249(1-2):71-9. PubMed ID: 12433435
[TBL] [Abstract][Full Text] [Related]
42. Solid dispersions of drugs in polyoxyethylene 40 stearate: dissolution rates and physico-chemical interactions [proceedings].
Kaur R; Grant DJ
J Pharm Pharmacol; 1979 Dec; 31 Suppl():48P. PubMed ID: 42723
[No Abstract] [Full Text] [Related]
43. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
44. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
[TBL] [Abstract][Full Text] [Related]
45. Solid phospholipid nano-particles: investigations into formulation and dissolution properties of griseofulvin.
Brinkmann-Trettenes U; Bauer-Brandl A
Int J Pharm; 2014 Jun; 467(1-2):42-7. PubMed ID: 24614583
[TBL] [Abstract][Full Text] [Related]
46. Drug-excipient interactions resulting from powder mixing. III: Solid state properties and their effect on drug dissolution.
Chowhan ZT; Chi LH
J Pharm Sci; 1986 Jun; 75(6):534-41. PubMed ID: 3735096
[TBL] [Abstract][Full Text] [Related]
47. Furosemide - Soluplus® Solid Dispersion: Development and Characterization.
Prasad R; Radhakrishnan P; Singh SK; Verma PRP
Recent Pat Drug Deliv Formul; 2017; 11(3):211-220. PubMed ID: 29189186
[TBL] [Abstract][Full Text] [Related]
48. Solid dispersion prepared by continuous cogrinding in an air jet mill.
Muehlenfeld C; Kann B; Windbergs M; Thommes M
J Pharm Sci; 2013 Nov; 102(11):4132-9. PubMed ID: 24105729
[TBL] [Abstract][Full Text] [Related]
49. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
[TBL] [Abstract][Full Text] [Related]
50. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties.
Zimmermann A; Millqvist-Fureby A; Elema MR; Hansen T; Müllertz A; Hovgaard L
Eur J Pharm Biopharm; 2009 Jan; 71(1):109-16. PubMed ID: 18619536
[TBL] [Abstract][Full Text] [Related]
51. [X-ray diffraction studies on tolbutamide solid dispersion].
Ma X; Rong SK; Wu QQ; Zhou GX
Yao Xue Xue Bao; 1992; 27(2):144-9. PubMed ID: 1414371
[TBL] [Abstract][Full Text] [Related]
52. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
[TBL] [Abstract][Full Text] [Related]
53. Griseofulvin---phenobarbital interaction: a formulation-dependent phenomenon.
Jamali F; Axelson JE
J Pharm Sci; 1978 Apr; 67(4):466-70. PubMed ID: 641749
[TBL] [Abstract][Full Text] [Related]
54. The Influence of Temperature and Viscosity of Polyethylene Glycol on the Rate of Microwave-Induced In Situ Amorphization of Celecoxib.
Hempel NJ; Dao T; Knopp MM; Berthelsen R; Löbmann K
Molecules; 2020 Dec; 26(1):. PubMed ID: 33383672
[TBL] [Abstract][Full Text] [Related]
55. Interactive mixture as a rapid drug delivery system.
Lee CC; Ong CL; Heng PW; Chan LW; Wong TW
Drug Dev Ind Pharm; 2008 Feb; 34(2):206-14. PubMed ID: 18302040
[TBL] [Abstract][Full Text] [Related]
56. The effect of some non-ionic surfactants and a polyoxyethylene glycol on the dissolution rate of griseofulvin.
Elworthy PH; Lipscomb FJ
J Pharm Pharmacol; 1968 Dec; 20(12):923-33. PubMed ID: 4388332
[No Abstract] [Full Text] [Related]
57. Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study.
Blaesi AH; Saka N
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():715-727. PubMed ID: 28866221
[TBL] [Abstract][Full Text] [Related]
58. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
Soliman MS; Khan MA
Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
[TBL] [Abstract][Full Text] [Related]
59. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
60. Improved dissolution of an insoluble drug using a 4-fluid nozzle spray-drying technique.
Chen R; Tagawa M; Hoshi N; Ogura T; Okamoto H; Danjo K
Chem Pharm Bull (Tokyo); 2004 Sep; 52(9):1066-70. PubMed ID: 15340191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
